A Pilot Study of the Bioavailability / Pharmacokinetics and Safety of Semaglutide with and without DehydraTECH in Healthy Volunteers

Clinika Research is conducting a follow-up study to a successful prior pilot study completed in late 2023.

 

The pilot study showed that administering Rybelsus® (oral semaglutide) with DehydraTECH™ improved the pharmacokinetics and glucose control more than Rybelsus alone.

 

Our follow-up study aims to replicate these findings with additional parameters unique to this study.